Home › Blasenkanker › District of Columbia › Washington
Blasenkanker klinische studies in Washington, DC
26 studies voor Blasenkanker zoeken deelnemers op locaties in en rond Washington (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruterenGezonde vrijwilligers welkom
- Walter Reed National Military Medical Center, Bethesda · 7 mijl verwijderd
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
RekruterenFase 3
- Sibley Memorial Hospital, Washington D.C.
Evaluation for NCI Surgery Branch Clinical Research Protocols
RekruterenObservatieonderzoek
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
RekruterenObservatieonderzoek
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mijl verwijderd
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruterenFase 2
- MedStar Georgetown University Hospital, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RekruterenFase 1/2
- Sibley Memorial Hospital Pharmacy Department, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekruterenFase 1
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
RekruterenFase 3
- Sibley Memorial Hospital ( Site 0849), Washington D.C.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RekruterenFase 3
- MedStar Washington Hospital Center, Washington D.C.
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- National Institutes of Health, Bethesda · 7 mijl verwijderd
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
RekruterenObservatieonderzoek
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RekruterenFase 1/2
- The George Washington Medical Faculty Associates, Washington D.C.
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
RekruterenFase 2/3
- Sibley Memorial Hospital, Washington D.C.
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RekruterenFase 2
- Medstar Washington Hospital Center, Washington D.C.
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
RekruterenFase 2
- Johns Hopkins University: Sibley Memorial Hospital, Washington D.C.
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
RekruterenFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Cancer Support Community Research & Training Institute, Washington D.C.
Renal Retention in High Grade Upper Tract Urothelial Cancer
RekruterenFase 2
- Johns Hopkins University: Sibley Memorial Hospital, Washington D.C.
Blue Light Cystoscopy With Cysview® Registry
RekruterenObservatieonderzoek
- Sibley Memorial Hospital, Washington D.C.
Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
Rekruteren
- Sibley Memorial Hospital, Washington D.C.
Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
RekruterenFase 3
- Sibley Memorial Hospital, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mijl verwijderd
- Massive Bio SYNERGY-AI site, Bethesda · 7 mijl verwijderd
Gender Related Coping and Survivorship for Genitourinary Cancers
RekruterenObservatieonderzoek
- Sibley Memorial Hospital, Washington D.C.
Blasenkanker studies in andere steden
- New York City, NY35 studies
- Nashville, TN31 studies
- Houston, TX31 studies
- Dallas, TX27 studies
- Boston, MA26 studies
- Baltimore, MD24 studies
- Los Angeles, CA24 studies
- St. Louis, MO22 studies
- Seattle, WA21 studies
- Chicago, IL21 studies
- Edison, NJ21 studies
- Philadelphia, PA21 studies
Andere studies in Washington
- Kanker (alle vormen)58 studies
- Niet-kleincellige longkanker55 studies
- Borstkanker46 studies
- Metastatische kanker43 studies
- Longkanker41 studies
- Prostaatkanker38 studies
- Obesitas33 studies
- Colorectale kanker29 studies
- Cardiovasculaire ziekte28 studies
- Acute myeloïde leukemie24 studies
- Eierstokkanker23 studies
- Lymfoom23 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.